| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 146, Issue 5 1490-1495, Copyright © 1991 by American Association of Immunologists
ARTICLES |
J Sun, H Link, T Olsson, BG Xiao, G Andersson, HP Ekre, C Linington and P Diener
Department of Neurology, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden.
The pathogenesis of multiple sclerosis (MS) is believed to involve an autoimmune component directed against the myelin sheath. One potential target Ag for such autoimmune attack is the myelin-oligodendrocyte glycoprotein (MOG) because an anti-MOG mAb has profound influence on the course of experimental autoimmune encephalomyelitis, which to some extent represents an experimental model of MS. Using single cell assays, we have evaluated T and B cell reactivities to MOG in MS patients and controls. T cell reactivity was estimated by counting the number of cells that secreted IFN-gamma in response to MOG, whereas B cell reactivity was estimated by enumerating cells secreting antibodies that bound to MOG. MOG reactive T cells were detected in the peripheral blood of the majority of the 16 MS patients examined (mean 1/7299 mononuclear cells), but infrequently and at lower numbers in samples from neurologic controls. MOG-reactive T cells were more frequent among MS patients' cerebrospinal fluid (CSF) mononuclear cells (mean 1/450 cells). The T cell response to MOG was evidently MHC class II restricted, because Fab fragments of a rabbit polyclonal anti HLA-DR antibodies abrogated the Ag-induced increase in number of cells that secreted IFN-gamma, as analyzed on CSF and PBMC from three patients with MS. Anti-MOG IgG antibody-secreting cells were detected in blood in 8 of 16 MS patients (mean 1/25,641 cells), but they were also strongly accumulated in CSF, being detected in 8 of 10 MS patients examined (mean 1/265 cells), while rarely found in controls. The findings imply that MOG may represent a pathogenetically important target Ag in MS.
This article has been cited by other articles:
|
|
 |
|
  C. Breithaupt, B. Schafer, H. Pellkofer, R. Huber, C. Linington, and U. Jacob Demyelinating Myelin Oligodendrocyte Glycoprotein-Specific Autoantibody Response Is Focused on One Dominant Conformational Epitope Region in Rodents J. Immunol., July 15, 2008; 181(2): 1255 - 1263. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Liu, F. Lin, M. G. Strainic, F. An, R. H. Miller, C. Z. Altuntas, P. S. Heeger, V. K. Tuohy, and M. E. Medof IFN-{gamma} and IL-17 Production in Experimental Autoimmune Encephalomyelitis Depends on Local APC-T Cell Complement Production J. Immunol., May 1, 2008; 180(9): 5882 - 5889. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. BETTELLI Building Different Mouse Models for Human MS Ann. N.Y. Acad. Sci., April 1, 2007; 1103(1): 11 - 18. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Komiyama, S. Nakae, T. Matsuki, A. Nambu, H. Ishigame, S. Kakuta, K. Sudo, and Y. Iwakura IL-17 Plays an Important Role in the Development of Experimental Autoimmune Encephalomyelitis J. Immunol., July 1, 2006; 177(1): 566 - 573. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Sheng, M. Jagodic, I. Dahlman, K. Becanovic, R. Nohra, M. Marta, E. Iacobaeus, T. Olsson, and E. Wallstrom Eae19, a New Locus on Rat Chromosome 15 Regulating Experimental Autoimmune Encephalomyelitis Genetics, May 1, 2005; 170(1): 283 - 289. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Correale and M. Fiol Activation of humoral immunity and eosinophils in neuromyelitis optica Neurology, December 28, 2004; 63(12): 2363 - 2370. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. T. Reder and J. J. Oger Anti-myelin oligodendrocyte glycoprotein antibodies in multiple sclerosis Neurology, June 8, 2004; 62(11): 1922 - 1923. [Full Text] [PDF]
|
|
|
|
 |
|
 R. Mantegazza, P. Cristaldini, P. Bernasconi, F. Baggi, R. Pedotti, I. Piccini, N. Mascoli, L. L. Mantia, C. Antozzi, O. Simoncini, et al. Anti-MOG autoantibodies in Italian multiple sclerosis patients: specificity, sensitivity and clinical association Int. Immunol., April 1, 2004; 16(4): 559 - 565. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Bettelli, M. Pagany, H. L. Weiner, C. Linington, R. A. Sobel, and V. K. Kuchroo Myelin Oligodendrocyte Glycoprotein-specific T Cell Receptor Transgenic Mice Develop Spontaneous Autoimmune Optic Neuritis J. Exp. Med., May 5, 2003; 197(9): 1073 - 1081. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Khare, M. Rodriguez, and C. S. David HLA class II transgenic mice authenticate restriction of myelin oligodendrocyte glycoprotein-specific immune response implicated in multiple sclerosis pathogenesis Int. Immunol., April 1, 2003; 15(4): 535 - 546. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S P Yentur, G Akman-Demir, M Eraksoy, and G Saruhan-Direskeneli Autoreactivity to myelin antigens related to HLA associations with multiple sclerosis Multiple Sclerosis, August 1, 2002; 8(4): 278 - 283. [Abstract] [PDF]
|
|
|
|
|
|
R. Weissert, J. Kuhle, K. L. de Graaf, W. Wienhold, M. M. Herrmann, C. Muller, T. G. Forsthuber, K.-H. Wiesmuller, and A. Melms High Immunogenicity of Intracellular Myelin Oligodendrocyte Glycoprotein Epitopes J. Immunol., July 1, 2002; 169(1): 548 - 556. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-C. von Budingen, S. L. Hauser, A. Fuhrmann, C. B. Nabavi, J. I. Lee, and C. P. Genain Molecular characterization of antibody specificities against myelin/oligodendrocyte glycoprotein in autoimmune demyelination PNAS, June 11, 2002; 99(12): 8207 - 8212. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. K. U. Koehler, C. P. Genain, B. Giesser, and S. L. Hauser The Human T Cell Response to Myelin Oligodendrocyte Glycoprotein: A Multiple Sclerosis Family-Based Study J. Immunol., June 1, 2002; 168(11): 5920 - 5927. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. R. Shadidi, T. Aarvak, S. Jeansson, J. E. Henriksen, J. B. Natvig, and K. M. Thompson T-cell responses to viral, bacterial and protozoan antigens in rheumatoid inflammation. Selective migration of T cells to synovial tissue Rheumatology, October 1, 2001; 40(10): 1120 - 1125. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Boon, H. P. M. Brok, J. Bauer, A. Ortiz-Buijsse, M. M. Schellekens, S. Ramdien-Murli, E. Blezer, M. van Meurs, J. Ceuppens, M. de Boer, et al. Prevention of Experimental Autoimmune Encephalomyelitis in the Common Marmoset (Callithrix jacchus) Using a Chimeric Antagonist Monoclonal Antibody Against Human CD40 Is Associated with Altered B Cell Responses J. Immunol., September 1, 2001; 167(5): 2942 - 2949. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Weissert, K. L. de Graaf, M. K. Storch, S. Barth, C. Linington, H. Lassmann, and T. Olsson MHC Class II-Regulated Central Nervous System Autoaggression and T Cell Responses in Peripheral Lymphoid Tissues Are Dissociated in Myelin Oligodendrocyte Glycoprotein-Induced Experimental Autoimmune Encephalomyelitis J. Immunol., June 15, 2001; 166(12): 7588 - 7599. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K G Warren and I. Catz Kinetic profiles of cerebrospinal fluid anti-MBP in response to intravenous MBP synthetic peptide DENP85VVHFFKNIVTP96RT in multiple sclerosis patients Multiple Sclerosis, October 1, 2000; 6(5): 300 - 311. [Abstract] [PDF]
|
|
|
|
|
|
M. Colombo, M. Dono, P. Gazzola, S. Roncella, A. Valetto, N. Chiorazzi, G. L. Mancardi, and M. Ferrarini Accumulation of Clonally Related B Lymphocytes in the Cerebrospinal Fluid of Multiple Sclerosis Patients J. Immunol., March 1, 2000; 164(5): 2782 - 2789. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Holz, B. Bielekova, R. Martin, and M. B. A. Oldstone Myelin-Associated Oligodendrocytic Basic Protein: Identification of an Encephalitogenic Epitope and Association with Multiple Sclerosis J. Immunol., January 15, 2000; 164(2): 1103 - 1109. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Reindl, C. Linington, U. Brehm, R. Egg, E. Dilitz, F. Deisenhammer, W. Poewe, and T. Berger Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study Brain, November 1, 1999; 122(11): 2047 - 2056. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R.-B. Lindert, C. G. Haase, U. Brehm, C. Linington, H. Wekerle, and R. Hohlfeld Multiple sclerosis: B- and T-cell responses to the extracellular domain of the myelin oligodendrocyte glycoprotein Brain, November 1, 1999; 122(11): 2089 - 2100. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Bronstein, R. L. Lallone, R. S. Seitz, G. W. Ellison, and L. W. Myers A humoral response to oligodendrocyte-specific protein in MS: A potential molecular mimic Neurology, July 1, 1999; 53(1): 154 - 154. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. B. Stevens, K. Chen, R. S. Seitz, E. E. Sercarz, and J. M. Bronstein Oligodendrocyte-Specific Protein Peptides Induce Experimental Autoimmune Encephalomyelitis in SJL/J Mice J. Immunol., June 15, 1999; 162(12): 7501 - 7509. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Schmidt Candidate autoantigens in multiple sclerosis Multiple Sclerosis, June 1, 1999; 5(3): 147 - 160. [Abstract] [PDF]
|
|
|
|
 |
|
 A. Karni, R. Bakimer-Kleiner, O. Abramsky, and A. Ben-Nun Elevated Levels of Antibody to Myelin Oligodendrocyte Glycoprotein Is Not Specific for Patients With Multiple Sclerosis Arch Neurol, March 1, 1999; 56(3): 311 - 315. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Hjelmstrom, A. E. Juedes, J. Fjell, and N. H. Ruddle Cutting Edge: B Cell-Deficient Mice Develop Experimental Allergic Encephalomyelitis with Demyelination After Myelin Oligodendrocyte Glycoprotein Sensitization J. Immunol., November 1, 1998; 161(9): 4480 - 4483. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. Leadbetter, C. R. Bourque, B. Devaux, C. D. Olson, G. H. Sunshine, S. Hirani, B. P. Wallner, D. E. Smilek, and M. P. Happ Experimental Autoimmune Encephalomyelitis Induced with a Combination of Myelin Basic Protein and Myelin Oligodendrocyte Glycoprotein Is Ameliorated by Administration of a Single Myelin Basic Protein Peptide J. Immunol., July 1, 1998; 161(1): 504 - 512. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Sellebjerg, M. Christiansen, and P. Garred MBP, anti-MBP and anti-PLP antibodies, and intrathecal complement activation in multiple sclerosis Multiple Sclerosis, June 1, 1998; 4(3): 127 - 131. [Abstract] [PDF]
|
|
|
|
|
|
J. E. Fenyk-Melody, A. E. Garrison, S. R. Brunnert, J. R. Weidner, F. Shen, B. A. Shelton, and J. S. Mudgett Experimental Autoimmune Encephalomyelitis Is Exacerbated in Mice Lacking the NOS2 Gene J. Immunol., March 15, 1998; 160(6): 2940 - 2946. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
